# Comgest Growth Europe Compounders
## SCHEDULE OF INVESTMENTS
As at 30 June 2020 (expressed in EUR)
|  | Acquisition | Fair Value | % Net |
| --- | --- | --- | --- |
| cost EUR | EUR | Assets |
|  |  |  |  |
| Equity securities | 3,646,199 | 3,745,000 | 94.20 |

| Transferable securities admitted to an official stock exchange listing | 3,646,199 | 3,745,000 | 94.20 |
| --- | --- | --- | --- |
|  |  |  |  |
| Financial assets at fair value through profit or loss | 3,646,199 | 3,745,000 | 94.20 |

Cash and other net assets		230,723	5.80 
Total net assets attributable to holders of redeemable participating shares	 3,975,723	100.00 
% of Total Assets
Transferable securities admitted to an official stock exchange listing	94.07
| Comgest Growth Europe Plus |  |
| --- | --- |
| SCHEDULE OF INVESTMENTS As at 30 June 2020 (expressed in EUR) |
| Security | Quantity/ Face value | Currency | Acquisition cost EUR | Fair Value EUR | % Net Assets |
| Financial assets at fair value through profit and loss |  |  |  |  |  |

Transferable securities admitted to an official stock exchange listing Equity securities
Denmark
Biotechnology
| Chr Hansen Holding A/S | 30,588 | DKK | 2,465,723 | 2,807,148 | 1.57 |
| --- | --- | --- | --- | --- | --- |
|  |  |  | 2,465,723 | 2,807,148 | 1.57 |
| Internet software SimCorp A/S | 9,449 | DKK | 797,212 | 906,463 | 0.51 |
|  |  |  | 797,212 | 906,463 | 0.51 |
| Pharmaceuticals and cosmetics Ambu A/S | 80,777 | DKK | 2,314,044 | 2,258,622 | 1.26 |
| Coloplast A/S - B Shares | 11,050 | DKK | 1,598,364 | 1,524,100 | 0.85 |
| Novo Nordisk A/S - B Shares | 153,834 | DKK | 9,200,301 | 8,862,833 | 4.96 |
|  |  |  | 13,112,709 | 12,645,555 | 7.07 |
|  |  |  |  |  |  |
| Total Denmark |  |  | 16,375,644 | 16,359,166 | 9.15 |
| France |  |  |  |  |  |
| Healthcare education and social services Orpea | 33,728 | EUR | 3,421,716 | 3,470,611 | 1.94 |
|  |  |  | 3,421,716 | 3,470,611 | 1.94 |
| Internet software Dassault Systèmes SE | 38,210 | EUR | 5,268,240 | 5,869,056 | 3.28 |
|  |  |  | 5,268,240 | 5,869,056 | 3.28 |
| News transmission Teleperformance | 7,651 | EUR | 1,585,452 | 1,728,361 | 0.97 |
|  |  |  | 1,585,452 | 1,728,361 | 0.97 |
| Pharmaceuticals and cosmetics EssilorLuxottica SA | 61,952 | EUR | 6,787,747 | 7,078,016 | 3.96 |
| L'Oreal SA | 21,315 | EUR | 5,411,787 | 6,089,696 | 3.41 |
|  |  |  | 12,199,534 | 13,167,712 | 7.37 |

Translation (ENDE, 2020-06-30):
# Comgest Growth Europe Compounders
WESENTLICHE BESTANDSVERÄNDERUNGEN für den Berichtszeitraum zum 30. Juni 2020
| Käufe 1 |  |  |  |
| --- | --- | --- | --- |
| Prozentualer Anteil |
| Wertpapier | Stück | Betrag (EUR) | Käufe |
| Roche Holding AG | 582 | 166.431 | 8,68 |
| Nestle SA | 1.283 | 118.784 | 6,20 |
| SAP SE | 1.133 | 113.561 | 5,93 |
| Linde PLC | 626 | 98.920 | 5,16 |
| LVMH Moët Hennessy Louis Vuitton SE | 283 | 97.574 | 5,09 |
| Medtronic PLC | 1.121 | 96.799 | 5,05 |
| Novo Nordisk A/S – B-Aktien | 1.917 | 96.308 | 5,03 |
| EssilorLuxottica SA | 827 | 94.890 | 4,95 |
| Industria de Diseno Textil SA | 3.938 | 94.091 | 4,91 |
| Accenture PLC | 566 | 89.262 | 4,66 |
| Pernod Ricard SA | 630 | 89.146 | 4,65 |
| Heineken NV | 1.031 | 87.428 | 4,56 |
| Unilever PLC | 1.528 | 79.749 | 4,16 |
| RELX PLC | 3.946 | 79.498 | 4,15 |
| Amadeus IT Group SA – A-Aktien | 1.378 | 71.971 | 3,76 |
| L'Oreal SA | 283 | 66.472 | 3,47 |
| Hermes International | 95 | 57.813 | 3,02 |
| Geberit AG | 140 | 57.518 | 3,00 |
| ASML Holding NV | 234 | 55.546 | 2,90 |
| Experian PLC | 1.919 | 50.885 | 2,66 |
| Wolters Kluwer NV | 821 | 49.577 | 2,59 |
| Givaudan SA | 18 | 48.266 | 2,52 |
| Coloplast A/S – B-Aktien | 266 | 30.165 | 1,56 |
| SGS SA | 12 | 25.892 | 1,34 |

| Verkäufe 2 |  |  |  |
| --- | --- | --- | --- |
| Prozentualer Anteil |
| Wertpapier | Stück | Betrag (EUR) | Verkäufe |
| Coloplast A/S – B-Aktien | 532 | 67.390 | 19,61 |
| SGS SA | 31 | 64.878 | 18,88 |
| Roche Holding AG | 205 | 56.889 | 16,56 |
| LVMH Moët Hennessy Louis Vuitton SE | 106 | 42.935 | 12,50 |
| Givaudan SA | 12 | 38.416 | 11,18 |
| Medtronic PLC | 286 | 25.712 | 7,48 |
| ASML Holding NV | 74 | 19.798 | 5,76 |
| Nestle SA | 185 | 18.922 | 5,51 |
| Novo Nordisk A/S – B-Aktien | 163 | 8.631 | 2,52 |

1 Steht für die gesamten Käufe im Berichtszeitraum.
2 Steht für die gesamten Verkäufe im Berichtszeitraum.